Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|September 13, 2020
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19Jonathan T Sims, Venkatesh Krishnan, Ching-Yun Chang, et al.
Frontiers in Immunology|December 27, 2021
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab TogetherLin Zhang, Josh Poorbaugh, Michael Dougan, et al.
The New England Journal of Medicine|October 28, 2020
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19Peter Chen, Ajay Nirula, Barry Heller, et al.
EMBO Molecular Medicine|May 31, 2020
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsJustin Stebbing, Venkatesh Krishnan, Stephanie de Bono, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Nature Communications|August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19Kara W Chew, Carlee Moser, Eric S Daar, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish Choudhary, et al.
Annals of the Rheumatic Diseases|October 18, 2025
Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid responseCecilia Ansalone, Samuel McAllister, Ethan S Pickerill, et al.
Cell Reports. Medicine|July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish C Choudhary, et al.
Pageof 5